Market Cap 6.86M
Revenue (ttm) 0.00
Net Income (ttm) 30.66M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 64,600
Avg Vol 112,858
Day's Range N/A - N/A
Shares Out 6.80M
Stochastic %K 38%
Beta -0.05
Analysts Strong Buy
Price Target N/A

Company Profile

PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company's cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer. It also develops CypCaps for pancreatic cancer and other soli...

Industry: Biotechnology
Sector: Healthcare
Phone: 917-595-2850
Fax: 917-595-2851
Address:
3960 Howard Hughes Parkway, Suite 500, Las Vegas, United States
Dfastpitchchic5
Dfastpitchchic5 Oct. 4 at 11:18 PM
0 · Reply
JJBurch
JJBurch Oct. 3 at 3:37 PM
$PMCB This is the hidden gem that’s going to make a FORTUNE of free cash flow from their investments in $QCLS These two are going to fly so hard First up, $QCLS parabolic move IMMINENT CONGRATS ALL
2 · Reply
BHWinehouse
BHWinehouse Oct. 3 at 1:15 PM
$QCLS $PMCB MYMD-1 PEER REVIEWED and for sale!! https://news.biobuzz.io/2025/07/16/mymd-pharmaceuticals-announces-publication-of-phase-1-data-for-oral-tnf-alpha-inhibitor-mymd-1-in-peer-reviewed-journal-drug-research/?utm_source=chatgpt.com
0 · Reply
Dfastpitchchic5
Dfastpitchchic5 Oct. 3 at 12:55 PM
0 · Reply
BHWinehouse
BHWinehouse Oct. 2 at 11:09 PM
$QCLS $PMCB Could be closer than we think... MYMD-1 will be sold, it's just a matter of when and for how much. AND oh yeah, the whole Lightsavor thing!
0 · Reply
Dfastpitchchic5
Dfastpitchchic5 Oct. 1 at 8:28 PM
0 · Reply
BHWinehouse
BHWinehouse Oct. 1 at 1:06 PM
$QCLS $PMCB i feel a deal is close
0 · Reply
highnihilism
highnihilism Oct. 1 at 12:01 PM
$PMCB Pharmacyte Biotech Trades: 4 | Total $: 510 | 1.37 × 90-Day Avg $: 372 | Call $: 510 | Put $: 0 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $LIND Lindblad Expeditions Trades: 3 | Total $: 510 | 0.16 × 90-Day Avg $: 3.3 K | Call $: 510 | Put $: 0 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $VSTS Vestis Trades: 10 | Total $: 505 | 0.02 × 90-Day Avg $: 21.6 K | Call $: 505 | Put $: 0 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $IRTC Irhythm Technologies Trades: 1 | Total $: 505 | 0.01 × 90-Day Avg $: 93.5 K | Call $: 505 | Put $: 0 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: –
0 · Reply
BHWinehouse
BHWinehouse Sep. 30 at 2:53 PM
$QCLS $PMCB I think JJ is closer to right than wrong on this one: PharmaCyte had approximately $15.5 million in cash and also holds over $30 million of securities as reflected in the Company’s most recent 10K. With the addition of the $7 million in proceeds from this financing, the Company’s balance sheet has been further strengthened, providing significant financial flexibility to support its ongoing business initiatives and strategic growth opportunities.
1 · Reply
Dfastpitchchic5
Dfastpitchchic5 Sep. 29 at 1:35 PM
0 · Reply
Latest News on PMCB
MyMD Pharmaceuticals Secures Strategic Investments

May 21, 2024, 9:00 AM EDT - 1 year ago

MyMD Pharmaceuticals Secures Strategic Investments


PharmaCyte Biotech Announces Final Results of Tender Offer

Jun 15, 2023, 9:15 AM EDT - 2 years ago

PharmaCyte Biotech Announces Final Results of Tender Offer


PharmaCyte Biotech Commences First Phase of Two-Phase Pig Study

Jul 21, 2022, 8:30 AM EDT - 3 years ago

PharmaCyte Biotech Commences First Phase of Two-Phase Pig Study


Is This A Good Time To Invest In PharmaCyte?

Jan 7, 2022, 2:59 AM EST - 4 years ago

Is This A Good Time To Invest In PharmaCyte?


Why Are PharmaCyte Shares Moving Higher On Thursday?

Sep 16, 2021, 1:51 PM EDT - 4 years ago

Why Are PharmaCyte Shares Moving Higher On Thursday?


Dfastpitchchic5
Dfastpitchchic5 Oct. 4 at 11:18 PM
0 · Reply
JJBurch
JJBurch Oct. 3 at 3:37 PM
$PMCB This is the hidden gem that’s going to make a FORTUNE of free cash flow from their investments in $QCLS These two are going to fly so hard First up, $QCLS parabolic move IMMINENT CONGRATS ALL
2 · Reply
BHWinehouse
BHWinehouse Oct. 3 at 1:15 PM
$QCLS $PMCB MYMD-1 PEER REVIEWED and for sale!! https://news.biobuzz.io/2025/07/16/mymd-pharmaceuticals-announces-publication-of-phase-1-data-for-oral-tnf-alpha-inhibitor-mymd-1-in-peer-reviewed-journal-drug-research/?utm_source=chatgpt.com
0 · Reply
Dfastpitchchic5
Dfastpitchchic5 Oct. 3 at 12:55 PM
0 · Reply
BHWinehouse
BHWinehouse Oct. 2 at 11:09 PM
$QCLS $PMCB Could be closer than we think... MYMD-1 will be sold, it's just a matter of when and for how much. AND oh yeah, the whole Lightsavor thing!
0 · Reply
Dfastpitchchic5
Dfastpitchchic5 Oct. 1 at 8:28 PM
0 · Reply
BHWinehouse
BHWinehouse Oct. 1 at 1:06 PM
$QCLS $PMCB i feel a deal is close
0 · Reply
highnihilism
highnihilism Oct. 1 at 12:01 PM
$PMCB Pharmacyte Biotech Trades: 4 | Total $: 510 | 1.37 × 90-Day Avg $: 372 | Call $: 510 | Put $: 0 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $LIND Lindblad Expeditions Trades: 3 | Total $: 510 | 0.16 × 90-Day Avg $: 3.3 K | Call $: 510 | Put $: 0 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $VSTS Vestis Trades: 10 | Total $: 505 | 0.02 × 90-Day Avg $: 21.6 K | Call $: 505 | Put $: 0 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $IRTC Irhythm Technologies Trades: 1 | Total $: 505 | 0.01 × 90-Day Avg $: 93.5 K | Call $: 505 | Put $: 0 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: –
0 · Reply
BHWinehouse
BHWinehouse Sep. 30 at 2:53 PM
$QCLS $PMCB I think JJ is closer to right than wrong on this one: PharmaCyte had approximately $15.5 million in cash and also holds over $30 million of securities as reflected in the Company’s most recent 10K. With the addition of the $7 million in proceeds from this financing, the Company’s balance sheet has been further strengthened, providing significant financial flexibility to support its ongoing business initiatives and strategic growth opportunities.
1 · Reply
Dfastpitchchic5
Dfastpitchchic5 Sep. 29 at 1:35 PM
0 · Reply
TruthTrader
TruthTrader Sep. 26 at 2:20 AM
$ORBS $PMCB $WLDS pmcb held it for years when it was trading 3 dollars. Snails in my back yard saw more action than this stock. The defifinition of dead money. Company issued shares/placement so that management could get paid for years to come. They said they cared about shareholder value but did nothing. $QURE take note here. I dumped at a loss. I will never buy a biotech stock again. Never!
1 · Reply
highnihilism
highnihilism Sep. 25 at 11:59 AM
Volume (Relative to 90-Day Average) → $PMCB Pharmacyte Biotech × 11.1 $AREB American Rebel Holdings × 1.8 $FGL Founder Group × 2.2 $JZXN Jiuzì Hldgs × 39.1 $NAK Northern Dynasty Minerals × 1.9
0 · Reply
ChartChartist
ChartChartist Sep. 24 at 4:46 PM
$PMCB looking for a nice one
0 · Reply
Dfastpitchchic5
Dfastpitchchic5 Sep. 24 at 4:41 PM
0 · Reply
JJBurch
JJBurch Sep. 24 at 1:45 PM
$QCLS $PMCB what a fucking steal at $1.00 or anywhere close to that!! $QCLS after ticker change, and new contracts announced which they already stated were in final negotiations, this goes $40-$50+ Congrats to all who have understood these plays We deserve this one. $SPY $OPEN
1 · Reply
BigPlaySnipers
BigPlaySnipers Sep. 24 at 1:30 PM
$PMCB = $QCLS sympathy
0 · Reply
ExecutiveEdge
ExecutiveEdge Sep. 20 at 2:06 AM
Everyone should have $PMCB on top watch $PMCB is a deeply discounted biotech with serious 20x potential, sitting near bottom with a derisked setup and massive upside. Its Cell in a Box technology targets hard to treat cancers like inoperable pancreatic cancer by delivering therapy directly to the tumor, aiming to reduce toxicity and improve outcomes. With completed safety studies, a strong cash position from past raises, and a pipeline that also includes malignant ascites and diabetes, PMCB offers multiple shots on goal. If FDA hurdles are cleared and clinical trials succeed, this microcap could quickly re rate and with low expectations baked in, even modest success could trigger explosive upside. $100 stock one day?? Or just a 10-20x like my $ORBS $WLDS call
1 · Reply
Dfastpitchchic5
Dfastpitchchic5 Sep. 18 at 6:25 PM
0 · Reply
peterpancake
peterpancake Sep. 18 at 2:14 PM
$PMCB look at NBTX huge skin cancer success going up
0 · Reply
dbr_island
dbr_island Sep. 17 at 10:41 PM
$PMCB there jr goes CAPS 👈 🚨LOAD ALERT🚨 YOU IGNORE SMART MONEY YOU IGNORE BIG MONEY👇💰💰💰 $ATCH
0 · Reply
Dfastpitchchic5
Dfastpitchchic5 Sep. 17 at 3:02 PM
0 · Reply
GluttonBoy
GluttonBoy Sep. 9 at 5:28 PM
TAIT stock is at zero borrow with shorts trapped and about to have a historic squeeze 3M float with no dilution and is a profitable semiconductor play Watching : $QMMM $BTOC $AIMD $HUBC $PMCB
0 · Reply